Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis

Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis

Cervical cancer is a global health challenge in women. Neoadjuvant chemotherapy (NACT) is a recent prospect for alternative cervical cancer treatments. This study investigated the efficacy of NACT against resectable cervical cancer based on the medium and long-term survival of patients with the dise...

Full description

Bibliographic Details
Main Authors: Yunbao Xu, Mengting Zhang, Jiaying Zhang, Derry Minyao Ng, Xiaoxiao Chen, Yuexiu Si, Yetan Shi, Xiangyuan Li, Danyi Mao, Lu Yang
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:Taiwanese Journal of Obstetrics & Gynecology
Subjects:
Neoadjuvant chemotherapy
Resectable cervical cancer
Prognosis
Meta-analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S1028455921000590

Internet

http://www.sciencedirect.com/science/article/pii/S1028455921000590

Similar Items